We use cookies to give you the best possible experience. If you continue, we’ll assume you are happy to receive the cookies we place. Privacy and cookies information.
News
-
“Landmark results” in key ovarian cancer research
22 October 2018
Results from a Phase III trial have demonstrated that lynparza (olaparib) therapy could cut the risk of disease progression or death by 70% in patients with newly-diagnosed, advanced BRCA mutated ovarian cancer.
Read more -
New treatment approach for advanced anal cancer
22 October 2018
A new approach to treating advanced anal cancer is safer and more effective than the most widely used current treatment, according to the first ever randomised clinical trial in this group of patients.
Read more -
Cancer trial shows treating the prostate with radiotherapy improves survival
21 October 2018
Treating the prostate with radiotherapy alongside standard treatment led to a 11 per cent increase in survival for some men with advanced prostate cancer, according to a study led by The Royal Marsden NHS Foundation Trust.
Read more -
Women may experience more side effects than men during gastric cancer chemotherapy
19 October 2018
Influence of sex on chemotherapy efficacy and toxicity in oesophagogastric (OG cancer): a pooled analysis of 4 randomised trials
Read more -
UK-first in robotic surgery at The Royal Marsden
16 October 2018
A patient has been discharged just over a week after undergoing a UK-first in robotic surgery at The Royal Marsden NHS Foundation Trust.
Read more -
Royal Marsden wins ‘Best UK Employer of the year’ award
5 October 2018
The Royal Marsden NHS Foundation Trust has been awarded the ‘Best UK employer of the year’ award at the Nursing Times Workforce Summit Awards 2018.
Read more -
The latest in lung cancer
26 September 2018
Clinicians from The Royal Marsden have been in Toronto over the past few days, presenting new research and providing expert comment at this year’s World Conference on Lung Cancer (WCLC).
Read more -
MR Linac- first ever treatment
24 September 2018
The Royal Marsden and The Institute of Cancer Research, London, have delivered the first ever treatment in the UK using a Magnetic Resonance Linear Accelerator (MR Linac) machine.
Read more -
2018 Staff Flu Vaccinations campaign at The Royal Marsden
24 September 2018
We at The Royal Marsden launch our 2018 Flu campaign to vaccinate staff working closely with patients.
Read more -
New Academic Appointments
21 September 2018
We proudly announce three new academic appointments for staff at The Royal Marsden NHS Foundation Trust.
Read more